Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Phase IIb trial investigating the effects of P1A on gastrointestinal microflora in hospitalised patients treated with IV ampicillin for serious upper- and lower respiratory tract infections

Trial Profile

Phase IIb trial investigating the effects of P1A on gastrointestinal microflora in hospitalised patients treated with IV ampicillin for serious upper- and lower respiratory tract infections

Completed
Phase of Trial: Phase II

Latest Information Update: 25 Oct 2007

At a glance

  • Drugs P1A (Primary) ; Ampicillin
  • Indications Bacterial infections; Intestinal infections; Respiratory tract infections
  • Focus Pharmacodynamics
  • Sponsors Ipsat Therapies
  • Most Recent Events

    • 25 Oct 2007 Primary endpoints met; results published in an Ipsat Therapies media release.
    • 06 Dec 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top